Antisense oligonucleotides against microRNA-21 reduced the proliferation and migration of human colon carcinoma cells

Cancer Cell International

Lin Xu¹  Jing Zheng¹  Na-lin Qin¹  Ya Zhou²  Meng-meng Guo¹  Juan-juan Zhao¹  Wen Zheng¹  Yong-ju Li¹  Yi-Jing Tao¹ 

[1] Department of Immunology, Zunyi Medical College, Zunyi 563003, Guizhou, China;Department of Medical Physics, Zunyi Medical College, Zunyi 563000, Guizhou, China

关键词: Phosphatase and tensin homolog (PTEN);    Antisense oligonucleotides (ASO);    Colon carcinoma;    MicroRNA-21;   

Others  :  1230688
DOI  :  10.1186/s12935-015-0228-7

 received in 2015-05-08, accepted in 2015-07-16,  发布年份 2015

【 摘 要 】

Background

Colon carcinoma is one of the commonly tumors that threaten human beings as its highly morbidity and mortality. Recent evidences suggested that microRNA-21 (miR-21) played an important role in the development of colon carcinoma and might be a potential biological marker for the diagnosis and prognosis of colon carcinoma. However, the potential effect of miR-21 based therapeutic studies in colon carcinoma remains to be fully elucidated.

Methods

In present study, we constructed an eukaryotic expression vector encoding antisense oligonucleotides against miR-21 (termed as p-miR-21-ASO) and the expression of miRNA-21 in human colon cancer was detected by Real-time PCR. To assess its possible effect on the proliferation and migration capacity of human colon carcinoma cells in vitro, CCK-8 assay, colony formation assay and cell invasion, as well as migration assay, were performed respectively. Moreover, PTEN, one of target molecules of miRNA-21, was analyzed by Western blot and Fluorescence activated cell sorter assay. Finally, the transduction of AKT and ERK pathways in human colon carcinoma cells was determined by Western blot.

Results

We found that transiently transfection of p-miR-21-ASO could efficiently decrease the relative expression of miR-21 in human colon carcinoma HCT116 cells, accompanied by impaired proliferation and clone formation. Furthermore, we found that down-regulation of miR-21 also could significantly abrogate the invasion and migration capacity in vitro, as well as the expression of vascular endothelial growth factor which is critical for the metastatic capacity of colon carcinoma cells. Mechanistic evidence showed that down-regulation of miR-21 increased the expression of its target molecule PTEN in HCT116 cells. Finally, we revealed that the expression level of both phosphor-ERK1/2 and phosphor-AKT also were altered.

Conclusions

Therefore, our data suggested miR-21 ASO against miR-21 might be a useful strategy to alter the expression of miR-21 in colon carcinoma cells, which was helpful for the development of miR-21-based therapeutic strategies against clinical colon carcinoma.

【 授权许可】

   
2015 Tao et al.

【 图 表 】

Fig.1.

Fig.2.

Fig.3.

Fig.4.

Fig.5.

【 参考文献 】

• [1]Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005; 294(10):1255-1259.
• [2]Jafri SH, Mills G. Lifestyle modification in colorectal cancer patients: an integrative oncology approach. Future Oncol. 2013; 9(2):207-218.
• [3]Matsushita Y, Nakamori S, Seftor EA, Hendrix MJ, Irimura T. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen. Exp Cell Res. 1991; 196(1):20-25.
• [4]Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD et al.. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA. 1991; 88(17):7792-7796.
• [5]Liang B, Shahbaz M, Wang Y, Gao H, Fang R, Niu Z et al.. Integrinbeta6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma. Clin Cancer Res. 2015; 21(5):1183-1195.
• [6]Mannucci S, Ghin L, Conti G, Tambalo S, Lascialfari A, Orlando T et al.. Magnetic nanoparticles from Magnetospirillum gryphiswaldense increase the efficacy of thermotherapy in a model of colon carcinoma. PLoS One. 2014; 9(10):e108959.
• [7]Li T, Leong MH, Harms B, Kennedy G, Chen L. MicroRNA-21 as a potential colon and rectal cancer biomarker. World J Gastroenterol. 2013; 19(34):5615-5621.
• [8]Yang CH, Yue J, Sims M, Pfeffer LM. The curcumin analog EF24 targets NF-kappaB and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS One. 2013; 8(8):e71130.
• [9]Echevarria-Vargas IM, Valiyeva F, Vivas-Mejia PE. Upregulation of miR-21 in cisplatin resistant ovarian cancer via JNK-1/c-Jun pathway. PLoS One. 2014; 9(5):e97094.
• [10]Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S et al.. MicroRNA profiles discriminate among colon cancer metastasis. PLoS One. 2014; 9(6):e96670.
• [11]Roy S, Yu Y, Padhye SB, Sarkar FH, Majumdar AP. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21. PLoS One. 2013; 8(7):e68543.
• [12]Nangia-Makker P, Yu Y, Vasudevan A, Farhana L, Rajendra SG, Levi E et al.. Metformin: a potential therapeutic agent for recurrent colon cancer. PLoS One. 2014; 9(1):e84369.
• [13]Bestas R, Kaplan MA, Isikdogan A. The correlation between serum VEGF levels and known prognostic risk factors in colorectal carcinoma. Hepatogastroenterology. 2014; 61(130):267-271.
• [14]Szajewski M, Kruszewski WJ, Lakomy J, Ciesielski M, Kawecki K, Jankun J et al.. VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma. Oncol Rep. 2014; 31(1):125-130.
• [15]Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007; 133(2):647-658.
• [16]Takei Y, Saga Y, Mizukami H, Takayama T, Ohwada M, Ozawa K et al.. Overexpression of PTEN in ovarian cancer cells suppresses i.p. dissemination and extends survival in mice. Mol Cancer Ther. 2008; 7(3):704-711.
• [17]Jiang BH, Liu LZ. PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res. 2009; 102:19-65.
• [18]Tian T, Nan KJ, Wang SH, Liang X, Lu CX, Guo H et al.. PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. Carcinogenesis. 2010; 31(7):1211-1219.
• [19]Harris VK, Coticchia CM, Kagan BL, Ahmad S, Wellstein A, Riegel AT. Induction of the angiogenic modulator fibroblast growth factor-binding protein by epidermal growth factor is mediated through both MEK/ERK and p38 signal transduction pathways. J Biol Chem. 2000; 275(15):10802-10811.
• [20]Xia C, Meng Q, Cao Z, Shi X, Jiang BH. Regulation of angiogenesis and tumor growth by p110 alpha and AKT1 via VEGF expression. J Cell Physiol. 2006; 209(1):56-66.
• [21]Fang J, Ding M, Yang L, Liu LZ, Jiang BH. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal. 2007; 19(12):2487-2497.
• [22]Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 2007; 282(19):14328-14336.
• [23]Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S et al.. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008; 27(15):2128-2136.
• [24]Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008; 283(2):1026-1033.
• [25]Zhang B, Farwell MA. microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med. 2008; 12(1):3-21.
• [26]Zheng SR, Guo GL, Zhai Q, Zou ZY, Zhang W. Effects of miR-155 antisense oligonucleotide on breast carcinoma cell line MDA-MB-157 and implanted tumors. Asian Pac J Cancer Prev. 2013; 14(4):2361-2366.
• [27]Xu L, Wen Z, Zhou Y, Liu Z, Li Q, Fei G et al.. MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway. Mol Biol Cell. 2013; 24(1):42-55.
• [28]Li YJ, Zhang YX, Wang PY, Chi YL, Zhang C, Ma Y et al.. Regression of A549 lung cancer tumors by anti-miR-150 vector. Oncol Rep. 2012; 27(1):129-134.
• [29]Qiang XF, Zhang ZW, Liu Q, Sun N, Pan LL, Shen J et al.. miR-20a promotes prostate cancer invasion and migration through targeting ABL2. J Cell Biochem. 2014; 115(7):1269-1276.
• [30]Li B, Ren S, Li X, Wang Y, Garfield D, Zhou S et al.. MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer. Lung Cancer. 2014; 83(2):146-153.
• [31]Fang L, Li H, Wang L, Hu J, Jin T, Wang J et al.. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget. 2014; 5(10):2974-2987.
• [32]Yang TS, Yang XH, Chen X, Wang XD, Hua J, Zhou DL et al.. MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN. FEBS Lett. 2014; 588(13):2162-2169.
• [33]Jiang J, Zhang Y, Yu C, Li Z, Pan Y, Sun C. MicroRNA-492 expression promotes the progression of hepatic cancer by targeting PTEN. Cancer cell Int. 2014; 14(1):95. BioMed Central Full Text
• [34]Setia S, Nehru B, Sanyal SN. The PI3K/Akt pathway in colitis associated colon cancer and its chemoprevention with celecoxib, a Cox-2 selective inhibitor. Biomed Pharmacother. 2014; 68(6):721-727.
• [35]Jagan IC, Deevi RK, Fatehullah A, Topley R, Eves J, Stevenson M et al.. PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system. Neoplasia. 2013; 15(11):1218-1230.
• [36]Setia S, Nehru B, Sanyal SN. Upregulation of MAPK/Erk and PI3K/Akt pathways in ulcerative colitis-associated colon cancer. Biomed Pharmacother. 2014; 68(8):1023-1029.
• [37]Auyeung KK, Mok NL, Wong CM, Cho CH, Ko JK. Astragalus saponins modulate mTOR and ERK signaling to promote apoptosis through the extrinsic pathway in HT-29 colon cancer cells. Int J Mol Med. 2010; 26(3):341-349.
• [38]Zhang Q, Ren W, Huang B, Yi L, Zhu H. MicroRNA-183/182/96 cooperatively regulates the proliferation of colon cancer cells. Mol Med Rep. 2015; 12(1):668-674.
• [39]Sun Y, Tian H, Wang L. Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway. Oncol Rep. 2015; 33(4):1828-1836.
• [40]Zhiyong C, Wentong L, Xiaoyang Y, Ling P. PTEN’s regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia. Med Oncol. 2012; 29(2):1084-1092.
• [41]Hamada K, Sasaki T, Koni PA, Natsui M, Kishimoto H, Sasaki J et al.. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 2005; 19(17):2054-2065.
• [42]Fassan M, Pizzi M, Giacomelli L, Mescoli C, Ludwig K, Pucciarelli S et al.. PDCD4 nuclear loss inversely correlates with miR-21 levels in colon carcinogenesis. Virchows Archiv. 2011; 458(4):413-419.